See more here: Bioxytran Secures $1.6 million SPA to Extinguish Note & Fund Clinical Development
See more here: Bioxytran Secures $1.6 million SPA to Extinguish Note & Fund Clinical Development
Read more: Valneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine and Announces Phase 3 Dose Decision
Excerpt from: Outlook Therapeutics® to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
Read more from the original source: Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit...
Read more from the original source: AB Science will participate in the Biomed Forum investors conference
The rest is here: Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025
Read more: Nusano to Present at Piper Sandler Next-Gen RadioPharma Symposium
See the article here: Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025
See more here: Avid Reminds Stockholders to Vote Today FOR the Transaction with GHO and Ampersand
Go here to read the rest: Tiziana Life Sciences Announces Discovery of New Immune Biomarkers in Multiple Sclerosis Patients Treated with Nasal Foralumab
Recent Comments